$XNCR

GUSTAFSON KURT A sold $67K of XNCR

GUSTAFSON KURT A sold 5,474 shares of Xencor Inc (XNCR) at $12.31 on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GUSTAFSON KURT A
Published Jun 17, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 8:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XNCR
Neutral
medium confidence
Mentioned
$XNCR
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XNCRNeutralLow
01

Why it matters

The disclosure provides a concrete, time-stamped insider activity datapoint, but the 10b5-1 structure generally reduces interpretability as a new fundamental signal.

02

Market read

Traders may monitor for follow-on insider activity, but this specific Form 4 is unlikely to drive a major repricing by itself.

03

What to watch

The filing doesn’t reveal whether other insiders or institutions are changing positions, so broader ownership/flow context could matter more than this single sale.

Relevance 2/10Novelty 6/10Timing: Filed June 17, 2026; sale executed June 15, 2026.

Background

The article is an SEC Form 4 insider transaction disclosure for Xencor, showing a director’s sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$XNCRNeutralMedium confidence
Context

Xencor disclosed a director open-market sale of 5,474 shares at $12.31 on a Rule 10b5-1 plan, totaling $67,384.94.

Expected impact

Likely limited/short-lived impact; any move would be more sentiment-driven than fundamentals.

Evidence & confidence

The filing is a primary Form 4, but the transaction is explicitly under a pre-arranged 10b5-1 plan and the dollar amount is modest versus typical market moves.

Market effects

No sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Because the sale is on a 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations; traders may discount it.

Key entities

  • Xencor Inc

    Issuer of the securities sold by a director under a Rule 10b5-1 plan.

  • Gustafson Kurt A

    Director who sold 5,474 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XNCRHighAI 8/10

Truist raises Xencor stock price target on kidney cancer drug data

Truist Securities raised its price target for Xencor (XNCR) to $40 from $29, citing positive clinical data for XmAb819 in kidney cancer. The stock has gained 17% in a week. Truist increased peak sales estimates to $1.1B and success probability to 35%. XNCR's market cap is $2.18B, with a 91% YTD return. Other analysts also upgraded price targets based on ESMO conference data.